ZIMELDINE IN DEPRESSIVE-ILLNESS - EFFICACY AND SAFETY DATA

被引：4

作者：

BURROWS, GD ^{[1
]}

NORMAN, TR ^{[1
]}

MARRIOTT, PF ^{[1
]}

DAVIES, B ^{[1
]}

机构：

[1] ROYAL MELBOURNE HOSP,PARKVILLE,VIC 3052,AUSTRALIA

来源：

ACTA PSYCHIATRICA SCANDINAVICA | 1983年 / 68卷

关键词：

D O I：

10.1111/j.1600-0447.1983.tb11101.x

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：31 / 40

页数：10

共 31 条

[1] PRELIMINARY CLINICAL TEST OF ZIMELIDINE (H 102-09), A NEW 5-HT UPTAKE INHIBITOR [J].

ABERG, A ;

HOLMBERG, G .

ACTA PSYCHIATRICA SCANDINAVICA, 1979, 59 (01) :45-58

[2] CONTROLLED CROSSOVER STUDY OF A 5-HT UPTAKE INHIBITING AND AN NA UPTAKE INHIBITING ANTI-DEPRESSANT [J].

ABERG, A .

ACTA PSYCHIATRICA SCANDINAVICA, 1981, 63 :244-255

[3]

Armitage P., 1975, SEQUENTIAL MED TRIAL

[4]

BENKERT O, 1977, ARZNEIMITTEL-FORSCH, V27-2, P2421

[5] BIOCHEMICAL EFFECTS OF ZIMELIDINE IN MAN [J].

BERTILSSON, L ;

TUCK, JR ;

SIWERS, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (06) :483-487

[6] CONTROLLED TRIAL OF AMITRIPTYLINE IN GENERAL PRACTICE [J].

BLASHKI, TG ;

MOWBRAY, R ;

DAVIES, B .

BMJ-BRITISH MEDICAL JOURNAL, 1971, 1 (5741) :133-+

[7] PHARMACOKINETICS OF ZIMELIDINE - SYSTEMIC AVAILABILITY OF ZIMELIDINE AND NORZIMELIDINE IN HUMAN VOLUNTEERS [J].

BROWN, D ;

SCOTT, DHT ;

SCOTT, DB ;

MEYER, M ;

WESTERLUND, D ;

LUNDSTROM, J .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) :111-116

[8] CARDIOVASCULAR EFFECTS OF AMITRIPTYLINE, MIANSERIN AND ZIMELIDINE IN DEPRESSED-PATIENTS [J].

BURGESS, CD ;

MONTGOMERY, SA ;

MONTGOMERY, DB ;

WADSWORTH, J .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY, 1980, 4 (4-5) :523-526

[9]

CARROLL BJ, 1973, ARCH GEN PSYCHIAT, V28, P361

[10] COMPARISON OF THE CARDIOVASCULAR EFFECTS OF AMITRIPTYLINE AND ZIMELIDINE USING THORACIC IMPEDANCE CARDIOGRAPHY [J].

CHRISTIE, JE ;

BROWN, D .

ACTA PSYCHIATRICA SCANDINAVICA, 1981, 63 :385-392

← 1 2 3 4 →